Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 4 of 4 for “"Silmitasertib"”.
-
The Effects of Cucurbitacin B and Silmitasertib on Metastasis and Itga6 Using the Zebrafish Tumor-Xenograft
… cancer cells (PC3) with cucurbitacin B and silmitasertib to see if the drugs were capable of upregulating or down regulating the activation of ITGA6 on the PC3 cell line. We executed tumor xenografts on zebrafish embryos to track metastasis. We then explored the efficacy of cucurbitacin B …
-
Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin Related Protein 2/3 Complex Activity and Invadopodia Function
… CK2α knockdown, and with the CK2α inhibitor Silmitasertib. Silmitasertib inhibits HNSCC collective invasion in tumor spheroids and orthotopic tongue tumors in mice. Although overall cancer incidence rates are declining across the United States, the incidence of head and neck squamous cell …
-
Pharmacological inhibition of CK2: the effect of an FDA designated orphan drug on pathology, neuroinflammation, and glial phenotypes in Huntington’s disease
… Htt aggregation, and improved neuronal function. Silmitasertib (CX-4945) is an FDA designated orphan drug that inhibits CK2. This study aims to investigate whether CX-4945 treatment ameliorates HD pathology. We treated prodromal and late symptomatic HD mice, and used a variety of …
-
Protein Kinase CK2alpha prime: A Unifying Regulator and Therapeutic Candidate in PolyQ Expansion Disorders and Tauopathies
… of CK2 using the FDA-designated orphan drug Silmitasertib (CX-4945) in PS19 mice and CK2α’ specific inhibitors in cell models of HTT and tau pathology. In vivo CX-4945 treatment ameliorated hyperactivity but did not impact cognitive behavior or pathological markers such as pTau and …